pharma news today obesity drugs glp-1 october 2025 What's next for innovation: A primer on the race reshaping and chronic disease care GLP-1 Receptor Agonist Market Valued

Pla Peris B, Alfaro M, Maravall Royo FJ, Abelln Galiana P, Prez Naranjo S, Gonzlez Boillos M (2022) Thyrotoxicosis following SARS-CoV-2 vaccination: a case series and discussion

Clinical Research: Neurogenesis and Synaptogenesis : Studies on Dihexa have shown significant promotion of synaptogenesis and neurogenesis

selective nicotinamide N-methyltransferase (NNMT) inhibitor Purity: 9899% (HPLC-verified, research grade) Appearance: Off-white to pale yellow crystalline powder (salt) or reddish-brown to orange powder depending on form or salt Physical Form: Lyophilized or crystalline solid powder

Bahcetepe N, Kutlubay Z, Yilmaz E, et al

Prolonged vitamin C supplementation and recovery from demanding exercise